Variations of N-acetylation level of peptidoglycan do not influence persistence of Lactococcus lactis in the gastrointestinal tract

International Journal of Food Microbiology

Volumn 144, Issue 1, 2010, Pages 29-34

  Watterlot, Laurie ^a   Meyrand, Mickael ^a   Gaide, Nicolas ^a   Kharrat, Pascale ^a   Blugeon, Sébastien ^a   Gratadoux, Jean Jacques ^a   Flores, Maria José ^a   Langella, Philippe ^a   Chapot Chartier, Marie Pierre ^a   Bermudez Humaran Luis G L G ^a  

^a UMR1319 MICALIS   (France)

Author keywords

E7 antigen; Gastrointestinal tract; Lactococcus lactis; Lysozyme; Peptidoglycan; PgdA

Indexed keywords

LYSOZYME; N ACETYLGLUCOSAMINE DEACETYLASE; PEPTIDOGLYCAN; PROTEIN E7; UNCLASSIFIED DRUG;

ACETYLATION; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DEACETYLATION; ENZYME ACTIVITY; GASTROINTESTINAL TRACT; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNE RESPONSE; LACTOCOCCUS LACTIS; MALE; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN TRANSPORT; WILD TYPE;

BACTERIA (MICROORGANISMS); HUMAN PAPILLOMAVIRUS TYPE 16; LACTOCOCCUS LACTIS; MUS; POSIBACTERIA;

EID: 78149471069     PISSN: 01681605     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijfoodmicro.2010.08.017     Document Type: Article

References (27)

1. Bermúdez-Humarán L.G. Lactococcus lactis as a live vector for mucosal delivery of therapeutic proteins. Human Vaccines 2009, 5:4.
2. Bermúdez-Humarán L.G., Langella P., Miyoshi A., Gruss A., Guerra R.T., Montes de Oca-Luna R., Le Loir Y. Production of human papillomavirus type 16 E7 protein in Lactococcus lactis. Applied Environmental Microbiology 2002, 68:917-922.
3. Bermúdez-Humarán L.G., Cortes-Perez N.G., Le Loir Y., Alcocer-Gonzalez J.M., Tamez-Guerra R.S., Montes de Oca-Luna R., Langella P. An inducible surface presentation system improves cellular immunity against E7 antigen after nasal administration with recombinant lactococci. Journal of Medical Microbiology 2004, 53:1-7.
4. Bermúdez-Humarán L.G., Cortes-Perez N.G., Le Loir Y., Gruss A., Rodriguez-Padilla C., Saucedo-Cardenas O., Langella P., Montes de Oca-Luna R. Fusion to a carrier protein and a synthetic propeptide enhances E7 HPV-16 production and secretion in Lactococcus lactis. Biotechnology Progress 2009, 19:1101-1104.
5. Boneca I.G., Dussurget O., Cabanes D., Nahori M.A., Sousa S., Lecuit M., Psylinakis E., Bouriotis V., Hugot J.P., Giovannini M., Coyle A., Bertin J., Namane A., Rousselle J.C., Cayet N., Prévost M.C., Balloy V., Chignard M., Philpott D.J., Cossart P., Girardin S.E. A critical role for peptidoglycan N-deacetylation in Listeria evasion from the host innate immune system. Proceedings of the National Academy of Sciences of the United States of America 2007, 104(3):997-1002. Jan 16.
6. Chopin A., Chopin M.C., Moillo-Batt A., Langella P. Two plasmid-determined restriction and modification systems in Streptococcus lactis. Plasmid 1984, 11:260-263.
7. Cortes-Perez N.G., Lefèvre F., Corthier G., Adel-Patient K., Langella P., Bermúdez-Humarán L.G. Influence of the route of immunization and the nature of the bacterial vector on immunogenicity of mucosal vaccines based on lactic acid bacteria. Vaccine 2007, 25:6581-6588.
8. de Ruyter P.G., Kuipers O.P., de Vos W.M. Controlled gene expression systems for Lactococcus lactis with the food-grade inducer nisin. Applied and Environmental Microbiology 1996, 62:3662-3667.
9. Dommett R., Zilbauer M., George J.T., Bajaj-Elliott M. Innate immune defence in the human gastrointestinal tract. Molecular Microbiology 2005, 42:903-912.
10. Drouault S., Corthier G., Ehlrich D., Renault R. Expression of the Staphylococcus hyicus lipase in Lactococcus lactis. Applied and Environmental Microbiology 2000, 66:588-598.
11. Fernandez A., Horn N., Wegmann U., Nicoletti C., Gasson M.J., Narbad A. Enhanced secretion of biologically active murine interleukin-12 by Lactococcus lactis. Applied Environmental Microbiology 2009, 75:869-871.
12. Gordon S., Todd J., Cohn Z.A. In vitro synthesis and secretion of lysozyme by mononuclear phagocytes. The Journal of Experimental Medicine 1974, 139:1228-1248.
13. Grangette C., Müller-Alouf H., Hols P., Goudercourt D., Delcour J., Turneer M., Mercenier A. Enhanced mucosal delivery of antigen with cell wall mutants of lactic acid bacteria. Infection and Immunity 2004, 72:2731-2737.
14. Gruzza M., Duval-Iflah Y., Ducluzeau R. Colonization of the digestive tract of germ-free mice by genetically engineered strains of Lactococcus lactis: study of recombinant DNA stability. Microbiology Releases 1992, 1:165-171.
15. Guédon E., Serror P., Ehrlich S.D., Renault P., Delorme C. Pleiotropic transcriptional repressor CodY senses the intracellular pool of branched-chain amino acids in Lactococcus lactis. Molecular Microbiology 2001, 40:1227-1239.
16. Hanniffy S., Wiedermann U., Repa A., Mercenier A., Daniel C., Fioramonti J., Tlaskolova H., Kozakova H., Israelsen H., Madsen S., Vrang A., Hols P., Delcour J., Bron P., Kleerebezem M., Wells J. Potential and opportunities for use of recombinant lactic acid bacteria in human health. Advances in Applied Microbiology 2007, 56:1-64.
17. Hébert L., Courtin P., Torelli R., Sanguinetti M., Chapot-Chartier M.P., Auffray Y., Benachour A. Enterococcus faecalis constitutes an unusual bacterial model in lysozyme resistance. Infection and Immunity 2007, 75(11):5390-5398. Nov.
18. Langella P., Le Loir Y., Ehrlich S.D., Gruss A. Efficient plasmid mobilization by pIP501 in Lactococcus lactis subsp. lactis. Journal of Bacteriology 1993, 175:5806-5813.
19. Lee P., Abdul-Wahid A., Faubert G.M. Comparison of the local immune response against Giardia lamblia cyst wall protein 2 induced by recombinant Lactococcus lactis and Streptococcus gordonii. Microbes Infections 2009, 11:20-28.
20. Mater D.D., Bretigny L., Firmesse O., Flores M.J., Mogenet A., Bresson J.L., Corthier G. Streptococcus thermophilus and Lactobacillus delbrueckii subsp. bulgaricus survive gastrointestinal transit of healthy volunteers consuming yogurt. Federation of European Microbiological Societies Microbiology Letters 2005, 250:185-187.
21. Medaglini D., Ciabattini A., Spinosa M.R., Maggi T., Marcotte H., Oggioni M.R., Pozzi G. Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice. Vaccine 2001, 19:1931-1939.
22. Meyrand M., Boughammoura A., Courtin P., Mézange C., Guillot A., Chapot-Chartier M.P. Peptidoglycan N-acetylglucosamine deacetylation decreases autolysis in Lactococcus lactis. Microbiology 2007, 153:3275-3285.
23. Renault P., Corthier G., Goupil N., Delorme C., Ehrlich S.D. Plasmid vectors for Gram-positive bacteria switching from high to low copy number. Gene 1996, 183:1227-1239.
24. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning: a Laboratory Manual 1989, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York. 2nd ed.
25. Steidler L., Robinson K., Chamberlain L., Schofield M., Remaut E., Le Page R.W.F., Wells J.M. Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine. Infection and Immunity 1998, 66:3183-3189.
26. Vesa T., Pochart P., Marteau P. Pharmacokinetics of Lactobacillus plantarum NCIMB 8826, Lactobacillus fermentum KLD, and Lactococcus lactis MG 1363 in the human gastrointestinal tract. Alimentary Pharmacology and Therapeutics 2000, 14:823-828.
27. Wells J.M., Mercenier A. Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nature Reviews Microbiology 2008, 6(5):349-362. May.